hellotayssir/FinQA_TAT-QA_financial_finetuning_dataset huggingface dataset:
DEPRECIATION AND AMORTIZATION
1 See “Accounting Policies” for more information.
1 See “Accounting Policies” for more information. Total depreciation and amortization increased this year primarily as a result of depreciation of right-of-use assets due to our adoption of IFRS 16 on January 1, 2019 and higher capital expenditures over the past several years. See “Capital Expenditures” for more information.
Table:
(In millions of dollars) | Years ended December 31 |  | 
 | 2019 | 2018 | %Chg
Depreciation | 2,297 | 2,174 | 6
Amortization | 16 | 37 | (57)
Depreciation and amortization before depreciation of right-of-use assets | 2,313 | 2,211 | 5
Depreciation of right-of-use assets 1 | 175 | - | n/m
Total depreciation and amortization | 2,488 | 2,211 | 13


Question: What was the Depreciation of right-of-use assets in 2019?
Answer: 175
Cash Conversion Cycle
The following table presents the components of our cash conversion cycle for the fourth quarter of each of the past three fiscal years:
(1) Days sales outstanding, referred to as DSO, calculates the average collection period of our receivables. DSO is based on ending accounts receivable and net revenue for each period. DSO is calculated by dividing accounts receivable by average net revenue per day for the current quarter (91 days for each of the fourth quarters presented above). The year over year increases in DSO in the fourth quarter of fiscal 2019 and fiscal 2018 were primarily due to less favorable shipping linearity and, in the case of fiscal 2019, one of our major distributors choosing not to take advantage of an early payment discount.
(2) Days inventory outstanding, referred to as DIO, measures the average number of days from procurement to sale of our products. DIO is based on ending inventory and cost of revenues for each period. DIO is calculated by dividing ending inventory by average cost of revenues per day for the current quarter. The increase in DIO in the fourth quarter of fiscal 2019 compared to the corresponding period of fiscal 2018 was primarily due to higher levels of finished goods on hand at the end of fiscal 2019. Compared to the corresponding period in fiscal 2017, the decrease in DIO in the fourth quarter of fiscal 2018 was due primarily to strong product sales towards the end of the fourth quarter of fiscal 2018.
(3) Days payables outstanding, referred to as DPO, calculates the average number of days our payables remain outstanding before payment. DPO is based on ending accounts payable and cost of revenues for each period. DPO is calculated by dividing accounts payable by average cost of revenues per day for the current quarter. DPO for the fourth quarter of fiscal 2019 was relatively unchanged compared to the fourth quarter of fiscal 2018, while it increased compared to the corresponding period in fiscal 2017 was primarily the result of improved vendor payables management and extensions of payment terms with our suppliers.
(4) The cash conversion cycle is the sum of DSO and DIO less DPO. Items which may cause the cash conversion cycle in a particular period to differ include, but are not limited to, changes in business mix, changes in payment terms (including extended payment terms from suppliers), the extent of shipment linearity, seasonal trends and the timing of revenue recognition and inventory purchases within the period.
Table:
 | Three Months Ended |  | 
(in days) |  |  | 
Three Months Ended | April 26, 2019 | April 27, 2018 | April 28, 2017
Days sales outstanding (1) | 70 | 58 | 45
Days inventory outstanding (2) | 21 | 18 | 26
Days payables outstanding (3) | (87) | (90) | (56)
Cash conversion cycle (4) | 3 | (14 ) | 15
Days may not add due to rounding |  |  | 


Question: What was the total percentage change in the cash conversion cycle between 2017 and 2019?
Answer: -80
Calculation: (3-15)/15
Restricted Stock Units
A summary of the Company’s restricted stock unit activity is as follows:
Performance-Based Restricted Stock Units
Performance-based restricted stock units are eligible to vest at the end of each fiscal year in a three-year performance period based on the Company’s annual growth rate in net sales and non-GAAP diluted earnings per share (subject to certain adjustments) over a multiple of four times the related results for the fourth quarter of 2018 relative to the growth rates for a peer group of companies for the same metrics and periods.
For the performance-based restricted stock units granted in 2019, 60% of each performance-based award is subject to the net sales metric for the performance period and 40% is subject to the non-GAAP diluted earnings per share metric for the performance period. The maximum percentage for a particular metric is2 50% of the target number of units subject to the award related to that metric, however, vesting of the performance stock units is capped at 30% and 100%, respectively, of the target number of units subject to the award in years one and two, respectively, of the three-year performance period.
As of December 31, 2019, the Company believes that it is probable that the Company will achieve performance metrics specified in the award agreement based on its expected revenue and non-GAAP diluted EPS results over the performance period and calculated growth rates relative to its peers’ expected results based on data available, as defined in the award agreement.
Table:
 | Number of Shares | Weighted-Average Grant-Date
 | (in thousands) | Fair Value per Share
Outstanding at December 31, 2018 | 3,263 | $20.23
Granted | 1,580 | 23.23
Vested | (1,541) | 20.16
Canceled | (378) | 21.52
Outstanding at December 31, 2019 | 2,924 | 21.72


Question: What is the average vested and canceled in 2019?
Answer: -959.5
Calculation: -(1,541 + 378) / 2
Unaudited Pro Forma Information - OpenEye
The following unaudited pro forma data is presented as if OpenEye were included in our historical consolidated statements of operations beginning January 1, 2018. These pro forma results do not necessarily represent what would have occurred if all the business combination had taken place on January 1, 2018, nor do they represent the results that may occur in the future.
This pro forma financial information includes our historical financial statements and those of our OpenEye business combination with the following adjustments: (i) we adjusted the pro forma amounts for income taxes, (ii) we adjusted for amortization expense assuming the fair value adjustments to intangible assets had been applied beginning January 1, 2018, and (iii) we adjusted for transaction fees incurred and reclassified them to January 1, 2018.
The pro forma adjustments were based on available information and upon assumptions that we believe are reasonable to reflect the impact of these acquisitions on our historical financial information on a supplemental pro forma basis, as follows (in thousands, except per share data):
Table:
 | Pro Forma | 
 | Year Ended December 31, | 
 | 2019 | 2018
Revenue | $527,550 | $451,013
Net income attributable to common stockholders | 51,075 | 13,264
Net income attributable to common stockholders per share - basic | $1.05 | $0.27
Net income attributable to common stockholders per share - diluted | $1.02 | $0.26


Question: Which years does the table provide information for revenue?
Answer: 2019, 2018
30. Financial instruments and financial risk management
The main purpose of the Group’s financial instruments, other than trade and other receivables, trade and other payables, contractual provisions and lease liabilities, is to fund the Group’s liquidity requirements.
All of the Group’s financial assets and liabilities are categorised as financial assets/liabilities stated at amortised cost, except for forward foreign currency exchange contracts, included within current other financial assets, that are designated as financial assets at fair value through profit or loss and corporate owned life insurance, amounting to $3.0 million (2018 $2.4 million), included within non-current trade and other receivables, that is designated as financial assets at fair value through profit or loss. These are shown in the below table:
The Group enters into derivative transactions, forward foreign currency exchange contracts, for the management of the Group’s foreign currency exposures when deemed appropriate.
The key objective of the Group’s treasury department is to manage the financial risks of the business and to ensure that sufficient liquidity is available to the Group. All treasury activity operates within a formal control framework. The Board has approved treasury policies and guidelines and periodically reviews treasury activities. Additionally, it is the Group’s policy that speculative treasury transactions are expressly forbidden.
Table:
 |  | 2019 | 2018
 | Notes | $ million | $ million
Non-current trade and other receivables | 20 | 5.7 | 3.5
Cash and cash equivalents | 22 | 183.2 | 121.6
Current trade and other receivables | 20 | 133.2 | 126.9
Current other financial assets | 20 | 0.1 | –
Financial assets |  | 322.2 | 252.0
Non-current other payables, excluding government grants | 23 | 0.8 | 4.4
Current trade payables, other payables and accruals | 23 | 75.4 | 57.1
Lease liabilities, current and non-current | 26 | 33.0 | –
Contractual provisions | 28 | 3.6 | 3.6
Financial liabilities |  | 112.8 | 65.1


Question: What are the components under Financial assets?
Answer: Non-current trade and other receivables, Cash and cash equivalents, Current trade and other receivables, Current other financial assets
3.6 PROFIT FOR THE YEAR
(1) Fiscal 2018 was restated to comply with IFRS 15 and to reflect a change in accounting policy as well as to reclassify results from Cogeco Peer 1 as discontinued operations. For further details, please consult the "Accounting policies" and "Discontinued operations" sections.
(2) The non-controlling interest represents a participation of 21% in Atlantic Broadband's results by Caisse de dépôt et placement du Québec ("CDPQ"), effective since the MetroCast acquisition on January 4, 2018.
Fiscal 2019 profit for the year from continuing operations and profit for the year from continuing operations attributable to owners of the Corporation decreased by 7.2% and 9.4%, respectively, as a result of: • last year's $94 million income tax reduction following the United States tax reform; and • the increase in depreciation and amortization mostly related to the impact of the MetroCast acquisition; partly offset by • higher adjusted EBITDA mainly as a result of the impact of the MetroCast acquisition; • the decrease in financial expense; and • the decrease in integration, restructuring and acquisition costs.
Fiscal 2019 profit for the year and profit for the year attributable to owners of the Corporation increased by 20.0% and 18.4%, respectively, mainly due to a profit for the year from discontinued operations of $75.4 million resulting from the sale of Cogeco Peer 1 in the third quarter of fiscal 2019 compared to a loss for the year from discontinued operations of $24.4 million for the prior year in addition to the elements mentioned above.
Table:
Years ended August 31, | 2019 | 2018 (1) | Change
(in thousands of dollars, except percentages and earnings per share) | $ | $ | %
Profit for the year from continuing operations | 356,908 | 384,578 | (7.2)
Profit for the year | 432,288 | 360,197 | 20.0
Profit for the year from continuing operations attributable to owners of the Corporation | 339,973 | 375,214 | (9.4)
Profit for the year attributable to owners of the Corporation | 415,353 | 350,833 | 18.4
Profit for the year from continuing operations attributable to non-controlling interest(2) | 16,935 | 9,364 | 80.9
Basic earnings per share from continuing operations | 6.89 | 7.61 | (9.5)
Basic earnings per share | 8.41 | 7.12 | 18.1


Question: What percentage of non-controlling interest represents a participation in Atlantic Broadband?
Answer: 21%
Item 6. Selected Financial Data
Five-Year Financial Summary in millions, except per share data (Fiscal years ended June 30,)
(a) Fiscal year 2019 included $1.2 million of acquisition-related costs related to LPW Technology Ltd. See Note 4 in the Notes to the Consolidated Financial Statements included in Item 8. “Financial Statements and Supplementary Data” of this report.
(b) Fiscal year 2018 included $68.3 million of discrete income tax net benefits related to the U.S. tax reform and other legislative changes. See Note 17 in the Notes to the Consolidated Financial Statements included in Item 8. “Financial Statements and Supplementary Data” of this report.
(c) Fiscal year 2017 included $3.2 million of loss on divestiture of business. See Note 4 in the Notes to the Consolidated Financial Statements included in Item 8. "Financial Statements and Supplementary Data" of this report.
(d) Fiscal year 2016 included $22.5 million of excess inventory write-down charges, $12.5 million of goodwill impairment charges and $18.0 million of restructuring and impairment charges including $7.6 million of impairment of intangible assets and property, plant and equipment and $10.4 million of restructuring costs related primarily to an early retirement incentive and other severance related costs.
(e) Fiscal year 2015 included $29.1 million of restructuring costs related principally to workforce reduction, facility closures and write-down of certain assets.
(f) The weighted average common shares outstanding for fiscal years 2016 and 2015 included 5.5 million and 0.9 million less shares, respectively, related to the share repurchase program authorized in October 2014. During the fiscal years ended June 30, 2016 and 2015, we repurchased 3,762,200 shares and 2,995,272 shares, respectively, of common stock for $123.9 million and $124.5 million, respectively.
See Item 7. “Management’s Discussion and Analysis of Financial Condition and Results of Operations” for discussion of factors that affect the comparability of the “Selected Financial Data”.
Table:
 | 2019 (a) | 2018(b) | 2017(c) | 2016(d)(f) | 2015 (e)(f)
Summary of Operations: |  |  |  |  | 
Net sales | $2,380.2 | $2,157.7 | $1,797.6 | $1,813.4 | $2,226.7
Operating income | $241.4 | $189.3 | $121.5 | $70.8 | $119.3
Net income | $167.0 | $188.5 | $47.0 | $11.3 | $58.7
Financial Position at Year-End: |  |  |  |  | 
Cash and cash equivalents | $27.0 | $56.2 | $66.3 | $82.0 | $70.0
Total assets | $3,187.8 | $3,007.0 | $2,878.1 | $2,794.3 | $2,902.6
Long-term debt, net of current portion | $550.6 | $545.7 | $550.0 | $611.3 | $603.8
Per Common Share: |  |  |  |  | 
Net earnings: |  |  |  |  | 
Basic | $3.46 | $3.96 | $0.99 | $0.23 | $1.11
Diluted | $3.43 | $3.92 | $0.99 | $0.23 | $1.11
Cash dividend-common | $0.80 | $0.72 | $0.72 | $0.72 | $0.72
Weighted Average Common Shares outstanding: |  |  |  |  | 
Basic | 47.7 | 47.2 | 47.0 | 48.1 | 52.6
Diluted | 48.1 | 47.6 | 47.1 | 48.2 | 52.7


Question: In which years was the amount of net sales provided?
Answer: 2019, 2018, 2017, 2016, 2015
Our 2019 net revenues decreased 1.1% compared to the prior year, primarily due to a decrease in volumes of approximately 8%, partially compensated by an increase in average selling prices of approximately 7%. The increase in the average selling prices was driven by favorable product mix of approximately 10%, partially offset by a negative pricing effect of approximately 3%.
Our 2018 net revenues increased 15.8% compared to the prior year, primarily due to increase in average selling prices of approximately 16%, while volumes remained substantially flat. The increase in the average selling prices was driven by favorable product mix of approximately 18%, partially offset by a negative pricing effect of approximately 2%. Our net revenues registered double-digit growth across all product groups and geographies.
In 2019, 2018 and 2017, our largest customer, Apple, accounted for 17.6%, 13.1% and 10.5% of our net revenues, respectively, reported within our three product groups.
Table:
 | Year Ended December 31, | Year Ended December 31, | Year Ended December 31, | % Variation | % Variation
 | 2019 | 2018 | 2017 | 2019 vs 2018 | 2018 vs 2017
 | (in millions) | (in millions) | (in millions) |  | 
Net sales | $9,529 | $9,612 | $8,308 | (0.9)% | 15.7%
Other revenues | 27 | 52 | 39 | (49.0) | 36.1
Net revenues | $9,556 | $9,664 | $8,347 | (1.1)% | 15.8%


Question: What are the average Net sales?
Answer: 9149.67
Calculation: (9,529+9,612+8,308) / 3
The movement of contract liabilities is mainly caused by the timing difference of the satisfaction of a performance of obligation and the consideration received from customers.
The Company recognized NT$3,815 million and NT$616 million, respectively, in revenues from the contract liabilities balance at the beginning of the period as performance obligations were satisfied for the years ended December 31, 2018 and 2019.
Table:
 | As of January 1,2018 | As of December 31,2018 | As of December 31,2019
 | NT$(In Thousands) | NT$(In Thousands) | NT$(In Thousands)
Sales of goods and services | $3,951,414 | $932,371 | $1,470,195
Current | $3,951,414 | $932,371 | $988,115
Noncurrent | — | — | 482,080
Total | $3,951,414 | $932,371 | $1,470,195


Question: What are the average Sales of goods and services for December 31, 2018 to 2019?
Answer: 1201283
Calculation: (932,371+1,470,195) / 2
humana inc . notes to consolidated financial statements 2014 ( continued ) the total intrinsic value of stock options exercised during 2007 was $ 133.9 million , compared with $ 133.7 million during 2006 and $ 57.8 million during 2005 . cash received from stock option exercises for the years ended december 31 , 2007 , 2006 , and 2005 totaled $ 62.7 million , $ 49.2 million , and $ 36.4 million , respectively . total compensation expense related to nonvested options not yet recognized was $ 23.6 million at december 31 , 2007 . we expect to recognize this compensation expense over a weighted average period of approximately 1.6 years . restricted stock awards restricted stock awards are granted with a fair value equal to the market price of our common stock on the date of grant . compensation expense is recorded straight-line over the vesting period , generally three years from the date of grant . the weighted average grant date fair value of our restricted stock awards was $ 63.59 , $ 54.36 , and $ 32.81 for the years ended december 31 , 2007 , 2006 , and 2005 , respectively . activity for our restricted stock awards was as follows for the year ended december 31 , 2007 : shares weighted average grant-date fair value .

Table:
 | shares | weighted average grant-date fair value
nonvested restricted stock at december 31 2006 | 1107455 | $ 45.86
granted | 852353 | 63.59
vested | -51206 ( 51206 ) | 56.93
forfeited | -63624 ( 63624 ) | 49.65
nonvested restricted stock at december 31 2007 | 1844978 | $ 53.61
the fair value of shares vested during the years ended december 31 , 2007 , 2006 , and 2005 was $ 3.4 million , $ 2.3 million , and $ 0.6 million , respectively .
total compensation expense related to nonvested restricted stock awards not yet recognized was $ 44.7 million at december 31 , 2007 .
we expect to recognize this compensation expense over a weighted average period of approximately 1.4 years .
there are no other contractual terms covering restricted stock awards once vested. .

Question: for the year ended december 31 , 2007 what was the ratio of the shares granted to the shares vested
Answer: 16.65
Calculation: divide(852353, 51206)
ii) Amounts in the financial statements
The assets and liabilities on the balance sheet are as follows:
3. Pensions continued
Table:
 | 2019 | 2018
 | £ million | £ million
Schemes in net asset position |  | 
UK defined benefit pension plan – Staff Plan | 7.8 | 1.1
UK defined benefit pension plan – Cash Plan | 1.0 | 0.9
 | 8.8 | 2.0
Schemes in net liability position |  | 
UK unfunded plan | (0.5) | (0.5)
Net pension plan surplus on the balance sheet | 8.3 | 1.5


Question: What was the change in the net pension plan surplus on the balance sheet?
Answer: 6.8
Calculation: 8.3-1.5
Restricted Stock Units
A summary of the Company’s restricted stock unit activity is as follows:
Performance-Based Restricted Stock Units
Performance-based restricted stock units are eligible to vest at the end of each fiscal year in a three-year performance period based on the Company’s annual growth rate in net sales and non-GAAP diluted earnings per share (subject to certain adjustments) over a multiple of four times the related results for the fourth quarter of 2018 relative to the growth rates for a peer group of companies for the same metrics and periods.
For the performance-based restricted stock units granted in 2019, 60% of each performance-based award is subject to the net sales metric for the performance period and 40% is subject to the non-GAAP diluted earnings per share metric for the performance period. The maximum percentage for a particular metric is2 50% of the target number of units subject to the award related to that metric, however, vesting of the performance stock units is capped at 30% and 100%, respectively, of the target number of units subject to the award in years one and two, respectively, of the three-year performance period.
As of December 31, 2019, the Company believes that it is probable that the Company will achieve performance metrics specified in the award agreement based on its expected revenue and non-GAAP diluted EPS results over the performance period and calculated growth rates relative to its peers’ expected results based on data available, as defined in the award agreement.
Table:
 | Number of Shares | Weighted-Average Grant-Date
 | (in thousands) | Fair Value per Share
Outstanding at December 31, 2018 | 3,263 | $20.23
Granted | 1,580 | 23.23
Vested | (1,541) | 20.16
Canceled | (378) | 21.52
Outstanding at December 31, 2019 | 2,924 | 21.72


Question: What was the number of shares granted in 2019?
Answer: 1,580
This section sets out the assets and liabilities subject to a committed plan to sell.
At 30 June 2019, assets held for sale includes Group properties (2018: assets and liabilities relating to the Petrol business, and other Group properties, have been classified as held for sale).
Assets are classified as held for sale if their carrying amount will be recovered principally through a sale transaction rather than continuing use and a sale is considered highly probable. They are measured at the lower of their carrying amount and fair value less costs to sell, except for assets such as deferred tax assets, assets arising from employee benefits, and financial assets which are specifically exempt from this measurement requirement.
An impairment loss is recognised for any initial or subsequent write-down of the asset to fair value less costs to sell. A gain is recognised for any subsequent increases in fair value less costs to sell of an asset, but not in excess of any cumulative impairment loss previously recognised. A gain or loss not previously recognised by the date of the sale of the asset is recognised at the date of derecognition. Assets are not depreciated or amortised while they are classified as held for sale. Interest and other expenses attributable to the liabilities classified as held for sale continue to be recognised.
Table:
 | 2019 | 2018
 | $M | $M
Property, plant and equipment | 209 | 666
Other assets | 16 | 155
Total assets classified as held for sale | 225 | 821
Provisions | – | 21
Total liabilities directly associated with assets held for sale | – | 21


Question: What is the difference in total assets classified as held for sale between 2018 and 2019?
Answer: 596
Calculation: 821 - 225